Navigator Medicines, Inc.
New Filing
CIK: 0002035715·Biotechnology·DELAWARE·Filed: Sep 25, 2026
Total Offering
$40,000,000
Amount Sold
$10,000,000
Investors
3
First Sale
Sep 18, 2026
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2024
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| TAUSIF BUTT | |
| STEPHEN BASIL THOMAS | |
| SCOTT FORREST | |
| WOUTER JOUSTRA | |
| KHUREM FAROOQ | |
| MATHIAS VINTHER | |
| KRISTIE GREBE |
Company
SEC Filing
0002035715-26-000005
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free